Press Releases

 
Featured
Press Release
Verge Genomics and Ferrer Announce Agreement to Co-Develop Clinical-Stage ALS Therapy VRG50635
Press Release
Press Release
Press Release
Verge Genomics to Present at Evercore ISI 2024 Emerging Biotech Conference
Press Release
Press Release
Press Release
Verge Genomics Announces Initiation of Proof-of-Concept Study for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with VRG50635
Press Release
Press Release
Press Release
Verge Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
Press Release
Press Release
Press Release
Verge Genomics Will Use Modality.AI in Its ALS Phase 1b Clinical Trial of Its Lead Drug Candidate VRG50635
Press Release
Press Release
Press Release
Verge Genomics and the Pritzker Neuropsychiatric Disorders Research Consortium Form Cutting Edge Schizophrenia Research Collaboration
Press Release
Press Release
Press Release
Verge Genomics Announces Artificial Intelligence-Enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases
Press Release
Press Release
Press Release
Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS
Press Release
Press Release
Press Release
Verge Genomics to Present at Mass General Brigham & Bank of America World Medical Innovation Forum
Press Release
Press Release
Press Release
Verge Genomics to Incorporate Emerald Digital Health Technology into its ALS Phase 1b Proof-of-Concept Clinical Trial
Press Release
Press Release
Press Release
Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023
Press Release
Press Release
Press Release
Verge Genomics Appoints Diego Cadavid, M.D., as Chief Medical Officer
Press Release
Press Release
Press Release
VERGE GENOMICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN NOVEMBER
Press Release
Press Release
Press Release
Alice Zhang, CEO & Co-founder of Verge Genomics, Recognized Today by Both Fortune and Fierce Biotech as a Pioneer in AI-Driven Drug Discovery
Press Release
Press Release
Press Release
Verge Genomics Initiates First-In-Human Dosing in Phase 1 Trial of VRG50635, A Novel Therapeutic for Amyotrophic Lateral Sclerosis
Press Release
Press Release
Press Release
Verge Genomics Appoints John Applegate as Chief Financial Officer
Press Release
Press Release
Press Release
Verge Genomics Honored by Goldman Sachs for Entrepreneurship
Press Release
Press Release
Press Release
Fierce Biotech Names Verge Genomics a 2022 “Fierce 15” Biotech Company
Press Release

Fierce Biotech Names Verge Genomics a 2022 “Fierce 15” Biotech Company

Press Release
Press Release
Alfred W. Sandrock, Jr., M.D., Ph.D., Joins Verge Genomics’ Board of Directors
Press Release
Press Release
Press Release
Verge Genomics to Present at 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022
Press Release
Press Release
Press Release
Verge Genomics Secures $98 Million in New Financing
Press Release
Press Release
Press Release
Verge Genomics Adds Independent Director Andrew Allen, M.D., Ph.D., to its Board of Directors
Press Release
Press Release
Press Release
Verge Genomics Announces Three-Year Collaboration With Lilly to Discover and Develop Novel Treatments Using Its AI-Driven All-in-Human Platform
Press Release
Press Release
Press Release
Verge Genomics Announces the Addition of Mario Saltarelli, M.D., Ph.D., to its Scientific Advisory Board
Press Release
Press Release
Press Release
Verge Genomics Announces Research Collaboration with the Sheffield Institute for Translational Neuroscience
Press Release
Press Release
Press Release
Verge Genomics joins the Neurofilament Light Surveillance Project to Accelerate New Approaches to Diagnosing and Treating Frontotemporal Dementia
Press Release
Press Release
Press Release
Verge Genomics Announces Publication of New Approach for Uncovering Novel Drug Targets from Human Genetics
Press Release
Press Release
Press Release
Verge Genomics Announces the Addition of Rita Balice-Gordon, PhD, to its Scientific Advisory Board
Press Release
Press Release
Press Release
Verge Genomics Awarded as Technology Pioneer by World Economic Forum
Press Release
Press Release
Press Release
Verge Genomics to advance its inhibitors of PIKfyve for the treatment of ALS and COVID-19
Press Release
Press Release